A new treatment based upon bi-specific antibodies may be possible for patients with T-cell acute lymphoblastic leukaemia who have not responded well to previous therapy, researchers have proposed.
Currently, relapsed or refractory T cell acute lym...
1 year ago
A leading blood cancer charity has appointed a new chief executive as it sets out to improve patient understanding of this disease group.
Helen Rowntree has been appointed Blood Cancer UK’s new permanent chief executive, it has been announced.
She...
1 year ago
